Stay updated with breaking news from Catherine Mummery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A trial currently taking place on 20 people, including four Brits, uses a new technology called 'RNA interference' which stops cells producing toxic proteins that cause Alzheimer's.
DR CATHERINE MUMMERY and PROF JOHN HARDY: Researchers told a packed audience at a medical conference that a new drug could slow the progression of Alzheimer's.
Rachel (right), 70, was diagnosed with Alzheimer's seven years ago. But Rachel was one of the lucky ones - she read a newspaper article about a trial for a new drug.
The anti-amyloid hopeful markedly reduced brain amyloid plaque and significantly slowed cognitive and functional decline in adults with early AD in the TRAILBLAZER-ALZ 2 trial.
A prospective treatment that 'silences genes' may slow the progression of Alzheimer's and may have the potential to reverse the disease, according to a small study by researchers at University College London.